53 related articles for article (PubMed ID: 9327242)
1. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2003 Sep; 47(9):3008-11. PubMed ID: 12937015
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Goldstein EJ; Conrads G; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2363-7. PubMed ID: 11451698
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of delafloxacin against anaerobic bacteria compared with other antimicrobials.
Cobo F; Franco-Acosta A; Martín-Hita L; Rodríguez-Granger J; Sampedro-Martínez A; Reguera-Márquez JA; Navarro-Marí JM
Anaerobe; 2024 Feb; 85():102816. PubMed ID: 38145709
[TBL] [Abstract][Full Text] [Related]
5. Investigation of
Ciftci N; Sargin I; Arslan G; Karakurt S; Arslan U
Nanomedicine (Lond); 2023 Oct; 18(24):1719-1731. PubMed ID: 37965902
[No Abstract] [Full Text] [Related]
6. Microbiological Assessment of Titanium Plates Coated with PLGA, Chitosan, and/or Meropenem: An In Vitro Study.
Al-Qubaisey M; Khounganian R; Al-Badah A
Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36358220
[TBL] [Abstract][Full Text] [Related]
7. "Off-Label" Medicine Use In Burned Children: Three-Year Retrospective Study.
Saputro ID; Putra ON; Hardiyono ; Mufidah E
Ann Burns Fire Disasters; 2021 Mar; 34(1):18-25. PubMed ID: 34054383
[TBL] [Abstract][Full Text] [Related]
8. Ultra-performance liquid chromatography-tandem mass spectrometric method for quantitation of the recently Food and Drug Administration approved combination of vaborbactam and meropenem in human plasma.
Kammoun AK; Khedr A; Khayyat AN; Hegazy MA
R Soc Open Sci; 2020 Jul; 7(7):200635. PubMed ID: 32874656
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948
[TBL] [Abstract][Full Text] [Related]
10. Dosing antibiotics in neonates: review of the pharmacokinetic data.
Rivera-Chaparro ND; Cohen-Wolkowiez M; Greenberg RG
Future Microbiol; 2017 Sep; 12(11):1001-1016. PubMed ID: 28758800
[TBL] [Abstract][Full Text] [Related]
11. Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution.
Biswal I; Arora BS; Kasana D; Neetushree
J Clin Diagn Res; 2014 May; 8(5):DC26-9. PubMed ID: 24995179
[TBL] [Abstract][Full Text] [Related]
12. Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.
Badawy AA; Zaher TI; Sharaf SM; Emara MH; Shaheen NE; Aly TF
World J Gastroenterol; 2013 Feb; 19(8):1271-7. PubMed ID: 23483064
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.
Cohen-Wolkowiez M; Poindexter B; Bidegain M; Weitkamp JH; Schelonka RL; Randolph DA; Ward RM; Wade K; Valencia G; Burchfield D; Arrieta A; Mehta V; Walsh M; Kantak A; Rasmussen M; Sullivan JE; Finer N; Rich W; Brozanski BS; van den Anker J; Blumer J; Laughon M; Watt KM; Kearns GL; Capparelli EV; Martz K; Berezny K; Benjamin DK; Smith PB;
Clin Infect Dis; 2012 Dec; 55(11):1495-502. PubMed ID: 22955430
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections.
Smith PB; Cohen-Wolkowiez M; Castro LM; Poindexter B; Bidegain M; Weitkamp JH; Schelonka RL; Ward RM; Wade K; Valencia G; Burchfield D; Arrieta A; Bhatt-Mehta V; Walsh M; Kantak A; Rasmussen M; Sullivan JE; Finer N; Brozanski BS; Sanchez P; van den Anker J; Blumer J; Kearns GL; Capparelli EV; Anand R; Benjamin DK;
Pediatr Infect Dis J; 2011 Oct; 30(10):844-9. PubMed ID: 21829139
[TBL] [Abstract][Full Text] [Related]
15. Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.
Mallalieu NL; Lennon S; Liu M; Kirkpatrick C; Robson R; Luedin E; Davies BE
Antimicrob Agents Chemother; 2008 Jul; 52(7):2360-6. PubMed ID: 18443123
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates.
Wexler HM; Engel AE; Glass D; Li C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4413-7. PubMed ID: 16189137
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR
Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639
[TBL] [Abstract][Full Text] [Related]
18. Two novel clinical presentations of Burkholderia cepacia infection.
Mukhopadhyay C; Bhargava A; Ayyagari A
J Clin Microbiol; 2004 Aug; 42(8):3904-5. PubMed ID: 15297563
[TBL] [Abstract][Full Text] [Related]
19. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.
Tomaselli F; Maier A; Matzi V; Smolle-Jüttner FM; Dittrich P
Antimicrob Agents Chemother; 2004 Jun; 48(6):2228-32. PubMed ID: 15155226
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
